Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PumaRx Registry Trial

NCT: NCT06805461 · RECRUITING

NCT IDNCT06805461
StatusRECRUITING
Start Date2025-08-01
Completion2029-09-03

Brief Summary

This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Frequently Asked Questions

What is PumaRx Registry Trial?

PumaRx Registry Trial is a clinical trial registered under NCT06805461. Current status: RECRUITING.

What is the status of NCT06805461?

The current status of NCT06805461 (PumaRx Registry Trial) is: RECRUITING.

When did PumaRx Registry Trial start?

PumaRx Registry Trial started on 2025-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑